摘要
目的:探讨菩人丹超微粉(PRD)对糖尿病大鼠视网膜的保护作用及其对核因子κB(NF-κB)信号通路的影响,并阐明其作用机制。方法:40只Wistar大鼠随机分为正常对照组、模型组、低剂量PRD组和高剂量PRD组。给药3个月后,测定各组大鼠血糖水平,RT-PCR法检测大鼠视网膜组织中血管内皮生长因子(VEGF)和血管生成素2(Ang-2)mRNA表达水平,Western blotting法检测大鼠视网膜组织中晚期糖基化终末产物(AGEs)、晚期糖基化终末产物受体(RAGE)、NF-κB、VEGF和Ang-2蛋白表达水平。结果:与正常对照组比较,模型组大鼠血糖水平及视网膜组织中VEGF、Ang-2mRNA表达水平和AGEs、RAGE、NF-κB、VEGF、Ang-2蛋白表达水平明显升高(P<0.05);与模型组比较,低和高剂量PRD组大鼠血糖水平及视网膜组织中VEGF、Ang-2 mRNA表达水平和AGEs、RAGE、NF-κB、VEGF、Ang-2蛋白表达水平明显降低(P<0.05)。结论:PRD可能通过特异性阻断AGEs/RAGE/NF-κB信号通路对糖尿病大鼠视网膜起保护作用。
Objective:To investigate the protective effect of Purendan superfine powder(PRD)on the retinopathy of the diabetic rats and its influence in the nuclear factor kappa B(NF-κB)signaling pathway,and to elucidate its mechanism of action.Methods:Forty Wistar rats were randomly divided into normal control group,model group,low dose of PRD group and high dose of PRD group.After 3 months of administration,the blood sugar levels of the rats in various groups were detected.The expression levels of vascular endothelial growth factor(VEGF)and angiogenin-2(Ang-2)mRNA in retina tissue of the rats were determined by RT-PCR.The expression levels of advanced glycation end products(AGEs),receptor for advanced glycation end products(RAGE),NF-κB,VEGF,Ang-2 proteins in retina tissue of the rats were determined by Western blotting method.Results:Compared with normal control group,the blood sugar level,the expression levels of VEGF,Ang-2 mRNA in retina tissue and the expression levels of AGEs,RAGE,NF-κB,VEGF,Ang-2 proteins in retina of the rats in model group were significantly increased(P〈0.05).Compared with model group,the blood sugar levels,the expression levels of VEGF and Ang-2 mRNA in retina tissue,and the expression levels of AGEs,RAGE,NF-κB,VEGF,Ang-2 proteins in retina tissue of the rats in low and high doses of PRD group were significantly decreased(P〈0.05).Conclusion:PRD may protect the retina of diabetic rats by specifically blocking the AGEs/RAGE/NF-κB signaling pathway.
作者
王海彬
董志军
郭立涛
石晶
董微丽
WANG Haibin;DONG Zhijun;GUO Litao;SHI Jing;DONG Weili(Department of Ophthalmology,Affiliated Hospital,Chengde Medical College,Chengde 067000,Chin)
出处
《吉林大学学报(医学版)》
CAS
CSCD
北大核心
2018年第4期759-763,共5页
Journal of Jilin University:Medicine Edition
基金
河北省中医药管理局科研基金资助课题(2014065)
关键词
菩人丹超微粉
糖尿病
实验性
视网膜病变
核因子ΚB信号通路
Purendan Superfine Powder
diabetes mellitus
experimental
retinopathy
nuclear factor kappa B signaling pathway